Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication.

Chang JY, Shim KN, Tae CH, Lee KE, Lee J, Lee KH, Moon CM, Kim SE, Jung HK, Jung SA.

BMC Gastroenterol. 2017 Jan 21;17(1):16. doi: 10.1186/s12876-017-0579-8.

2.

Optimal First-Line Treatment for <i>Helicobacter pylori</i> Infection: Recent Strategies.

Lee JY, Park KS.

Gastroenterol Res Pract. 2016;2016:9086581. doi: 10.1155/2016/9086581. Review.

3.

Pathophysiological and clinical aspects of gastric hyperplastic polyps.

Markowski AR, Markowska A, Guzinska-Ustymowicz K.

World J Gastroenterol. 2016 Oct 28;22(40):8883-8891. Review.

4.

Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical note.

Losurdo G, Giorgio F, Iannone A, Principi M, Barone M, Di Leo A, Ierardi E.

World J Gastroenterol. 2016 Oct 14;22(38):8638-8640.

5.

Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trial.

Das R, Sureshkumar S, Sreenath GS, Kate V.

Saudi J Gastroenterol. 2016 Jul-Aug;22(4):309-15. doi: 10.4103/1319-3767.187605.

6.

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis.

Kim BJ, Kim HS, Song HJ, Chung IK, Kim GH, Kim BW, Shim KN, Jeon SW, Jung YJ, Yang CH, Kim JH, Kim TH, Kim SG, Shin WG, Kim SM, Han SW, Lee JH, Kim KH, Park SK, Park BJ, Lee J, Kim JG; Korean College of Helicobacter and Upper Gastrointestinal Research..

J Korean Med Sci. 2016 Aug;31(8):1246-53. doi: 10.3346/jkms.2016.31.8.1246.

7.

Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.

Lee JY, Kim N, Park KS, Kim HJ, Park SM, Baik GH, Shim KN, Oh JH, Choi SC, Kim SE, Kim WH, Park SY, Kim GH, Lee BE, Jo Y, Hong SJ.

BMC Gastroenterol. 2016 Jul 26;16(1):79. doi: 10.1186/s12876-016-0490-8.

8.

Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.

Lin LC, Hsu TH, Huang KW, Tam KW.

World J Gastroenterol. 2016 Jun 21;22(23):5445-53. doi: 10.3748/wjg.v22.i23.5445.

9.

Hybrid, sequential and concomitant therapies for Helicobacter pylori eradication: A systematic review and meta-analysis.

Song ZQ, Zhou LY.

World J Gastroenterol. 2016 May 21;22(19):4766-75. doi: 10.3748/wjg.v22.i19.4766.

10.

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.

Chuah SK, Liang CM, Lee CH, Chiou SS, Chiu YC, Hu ML, Wu KL, Lu LS, Chou YP, Chang KC, Kuo CH, Kuo CM, Hu TH, Tai WC.

Medicine (Baltimore). 2016 May;95(19):e3586. doi: 10.1097/MD.0000000000003586.

11.

Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.

Kim JS, Kim BW, Hong SJ, Kim JI, Shim KN, Kim JH, Baik GH, Kim SW, Song HJ, Kim JH.

Gut Liver. 2016 Jul 15;10(4):556-61. doi: 10.5009/gnl15470.

12.

Hybrid Therapy Regimen for Helicobacter Pylori Eradication.

Song ZQ, Liu J, Zhou LY.

Chin Med J (Engl). 2016 Apr 20;129(8):992-9. doi: 10.4103/0366-6999.179803. Review.

13.

A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of "Geographic Weight".

Losurdo G, Iannone A, Giorgio F, Ierardi E, Di Leo A, Principi M.

Saudi J Gastroenterol. 2016 Jan-Feb;22(1):77-8. doi: 10.4103/1319-3767.173763. No abstract available.

14.

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication.

Jung SM, Cheung DY, Kim JI, Kim I, Seong H.

Gastroenterol Res Pract. 2016;2016:1293649. doi: 10.1155/2016/1293649.

15.

Treatment of Helicobacter pylori infection: Current and future insights.

Safavi M, Sabourian R, Foroumadi A.

World J Clin Cases. 2016 Jan 16;4(1):5-19. doi: 10.12998/wjcc.v4.i1.5. Review.

16.

Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

Kefeli A, Basyigit S, Yeniova AO, Kefeli TT, Aslan M, Tanas O.

Bosn J Basic Med Sci. 2016 Jan 1;16(1):52-7. doi: 10.17305/bjbms.2016.660.

17.

Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.

Hsu PI, Lin PC, Graham DY.

World J Gastroenterol. 2015 Dec 7;21(45):12954-62. doi: 10.3748/wjg.v21.i45.12954. Review.

19.

The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.

Basyigit S, Kefeli A, Sapmaz F, Yeniova AO, Asilturk Z, Hokkaomeroglu M, Uzman M, Nazligul Y.

Bosn J Basic Med Sci. 2015 Oct 25;15(4):50-4. doi: 10.17305/bjbms.2015.573.

20.

Polymorphisms in mucin genes in the development of gastric cancer.

Wen R, Gao F, Zhou CJ, Jia YB.

World J Gastrointest Oncol. 2015 Nov 15;7(11):328-37. doi: 10.4251/wjgo.v7.i11.328. Review.

Items per page

Supplemental Content

Loading ...
Support Center